Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,752 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Minimal residual disease in early phase of chemotherapy reflects poor outcome in children with acute lymphoblastic leukemia--a retrospective study by the Children's Cancer and Leukemia Study Group in Japan.
Okamoto T, Yokota S, Katano N, Seriu T, Nakao M, Taniwaki M, Watanabe A, Asami K, Kikuta A, Koizumi S, Kawakami T, Ohta S, Miyake M, Watanabe T, Iwai A, Kamitamari A, Ijichi O, Hyakuna N, Mimaya J, Fujimoto T, Tsurusawa M. Okamoto T, et al. Among authors: watanabe t, watanabe a. Leuk Lymphoma. 2002 May;43(5):1001-6. doi: 10.1080/10428190290021641. Leuk Lymphoma. 2002. PMID: 12148878
Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia.
Atsuta Y, Suzuki R, Nagamura-Inoue T, Taniguchi S, Takahashi S, Kai S, Sakamaki H, Kouzai Y, Kasai M, Fukuda T, Azuma H, Takanashi M, Okamoto S, Tsuchida M, Kawa K, Morishima Y, Kodera Y, Kato S; Japan Cord Blood Bank Network. Atsuta Y, et al. Blood. 2009 Feb 19;113(8):1631-8. doi: 10.1182/blood-2008-03-147041. Epub 2008 Dec 22. Blood. 2009. PMID: 19104080 Free article. Clinical Trial.
Minimal residual disease-based augmented therapy in childhood acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.
Yamaji K, Okamoto T, Yokota S, Watanabe A, Horikoshi Y, Asami K, Kikuta A, Hyakuna N, Saikawa Y, Ueyama J, Watanabe T, Okada M, Taga T, Kanegane H, Kogawa K, Chin M, Iwai A, Matsushita T, Shimomura Y, Hori T, Tsurusawa M; Japanese Childhood Cancer Leukemia Study Group. Yamaji K, et al. Among authors: watanabe t, watanabe a. Pediatr Blood Cancer. 2010 Dec 15;55(7):1287-95. doi: 10.1002/pbc.22620. Pediatr Blood Cancer. 2010. PMID: 20535816 Clinical Trial.
HLA-identical sibling peripheral blood stem cell transplantation in children and adolescents.
Watanabe T, Takaue Y, Kawano Y, Koike K, Kikuta A, Imaizumi M, Watanabe A, Eguchi H, Ohta S, Horikoshi Y, Iwai A, Makimoto A, Kuroda Y; Peripheral Blood Stem Cell Transplantation Study Group of Japan. Watanabe T, et al. Among authors: watanabe a. Biol Blood Marrow Transplant. 2002;8(1):26-31. doi: 10.1053/bbmt.2002.v8.pm11846353. Biol Blood Marrow Transplant. 2002. PMID: 11846353 Free article.
Nelarabine, intensive L-asparaginase, and protracted intrathecal therapy for newly diagnosed T-cell acute lymphoblastic leukaemia in children and young adults (ALL-T11): a nationwide, multicenter, phase 2 trial including randomisation in the very high-risk group.
Sato A, Hatta Y, Imai C, Oshima K, Okamoto Y, Deguchi T, Hashii Y, Fukushima T, Hori T, Kiyokawa N, Kato M, Saito S, Anami K, Sakamoto T, Kosaka Y, Suenobu S, Imamura T, Kada A, Saito AM, Manabe A, Kiyoi H, Matsumura I, Koh K, Watanabe A, Miyazaki Y, Horibe K. Sato A, et al. Among authors: watanabe a. Lancet Haematol. 2023 Jun;10(6):e419-e432. doi: 10.1016/S2352-3026(23)00072-8. Epub 2023 May 8. Lancet Haematol. 2023. PMID: 37167992 Clinical Trial.
Outcome of TCF3-PBX1 positive pediatric acute lymphoblastic leukemia patients in Japan: a collaborative study of Japan Association of Childhood Leukemia Study (JACLS) and Children's Cancer and Leukemia Study Group (CCLSG).
Asai D, Imamura T, Yamashita Y, Suenobu S, Moriya-Saito A, Hasegawa D, Deguchi T, Hashii Y, Endo M, Hatakeyama N, Kawasaki H, Hori H, Horibe K, Yumura-Yagi K, Hara J, Watanabe A, Kikuta A, Oda M, Sato A; Japan Association of Childhood Leukemia Study (JACLS) & Children's Cancer and Leukemia Study Group (CCLSG). Asai D, et al. Among authors: watanabe a. Cancer Med. 2014 Jun;3(3):623-31. doi: 10.1002/cam4.221. Epub 2014 Feb 28. Cancer Med. 2014. PMID: 24578304 Free PMC article.
Nationwide survey of pediatric hypodiploid acute lymphoblastic leukemia in Japan.
Ishimaru S, Okamoto Y, Imai C, Sakaguchi H, Taki T, Hasegawa D, Cho Y, Kakuda H, Sano H, Manabe A, Imamura T, Kato M, Arakawa Y, Shimonodan H, Sato A, Suenobu S, Inukai T, Watanabe A, Kawano Y, Kikuta A, Horibe K, Ohara A, Koh K. Ishimaru S, et al. Among authors: watanabe a. Pediatr Int. 2019 Nov;61(11):1103-1108. doi: 10.1111/ped.14006. Epub 2019 Nov 21. Pediatr Int. 2019. PMID: 31519067
Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomaternal microchimerism.
Ichinohe T, Uchiyama T, Shimazaki C, Matsuo K, Tamaki S, Hino M, Watanabe A, Hamaguchi M, Adachi S, Gondo H, Uoshima N, Yoshihara T, Hatanaka K, Fujii H, Kawa K, Kawanishi K, Oka K, Kimura H, Itoh M, Inukai T, Maruya E, Saji H, Kodera Y; Japanese Collaborative Study Group for NIMA-Complementary Haploidentical Stem Cell Transplantation. Ichinohe T, et al. Among authors: watanabe a. Blood. 2004 Dec 1;104(12):3821-8. doi: 10.1182/blood-2004-03-1212. Epub 2004 Jul 27. Blood. 2004. PMID: 15280193 Free article.
4,752 results